Publications

2025 | Transplantation and Cellular Therapy

The caregiver paradigm in hematopoietic cell transplant: Current and future directions.

Authors:

Tweeten B, Randall J, Barata A, Khera N, Griffith MA, DeSalvo AM, Schoeppner K, Preussler JM

2025 | Journal of Clinical Oncology

HLA-mismatched unrelated donor hematopoietic cell transplantation with post-transplantation cyclophosphamide.

Authors:

Al Malki MM, Bo-Subait S, Logan B, Olson J, Kou J, Smith S, Leckrone E, Wu J, Stefanski HE, Auletta JJ, Spellman SR, Malmberg C, Askar M, Cusatis R, Shaffer BC, Modi D, Khimani F, Gooptu M, Hamadani M, Madbouly A, Maiers M, Fingerson S, Cook R, Ballen K, Loren A, Larkin K, Arai S, Qayed M, Choi SW, Broglie L, Shaw BE, Devine SM, Jimenez Jimenez AM

2025 | Transplantation and Cellular Therapy

An ASTCT, CIBMTR, EBMT, and APBMT consensus statement defining response criteria for hematopoietic cell transplantation associated thrombotic microangiopathy (TA-TMA) directed therapy: Consensus response criteria for TA-TMA.

Authors:

Schoettler ML, Gavriilaki E, Carreras E, Cho BK, Dandoy CE, Ho VT, Jodele S, Moiseev I, Sánchez-Ortega I, Srivastava A, Atsuta Y, Carpenter PA, Koreth J, Kröger N, Ljungman P, Page K, Popat U, Shaw BE, Sureda A, Soiffer R, Vasu S

2025 | Future Oncology

Real-world treatment of large B-cell lymphoma with chimeric antigen receptor T-cell therapy after loncastuximab tesirine: a plain language summary.

Authors:

Hamadani M, Lucero M, DeVos JD, Chen L

2025 | Blood Advances

Infection after CD19 chimeric antigen receptor T cell therapy for large B cell lymphoma: Real-world analysis from CIBMTR.

Authors:

Wudhikarn K, Herr MM, Chen M, Martens MJ, Baird JH, Gowda L, Rangarajan HG, Bilal AM, Kharfan-Dabaja MA, Williams KM, Ganguly S, Young JH, Sharma A, Fatobene G, Jain T, Kanakry CH, Modi D, Grover NS, Salem B, Batista MV, Vergidis P, Yin DE, Beitinjaneh AM, Kelkar AH, Nishihori T, Holter-Chakrabarty J, Gergis U, Smith M, El Boghdadly Z, Dandoy CE, Huppler AH, Murthy H, Perales MA, Chemaly RF, Hill JA, Riches M, Auletta JJ

2025 | EJHaem

Efficacy of TBI-based intensified myeloablative regimens for acute leukemia – an international collaborative study.

Authors:

Arai Y, Brazauskas R, He N, Al-Homsi AS, Chhabra S, Battiwalla M, Yanada M, Steinberg A, Diaz Perez MA, Hong S, Kanda J, Bashey A, Frangoul HA, Badawy SM, Verdonck LF, Lazarus HM, Yared JA, Hashem H, Sharma A, Aljurf M, Dias AL, Abid MB, Wirk B, Freytes CO, Zeidan AM, Gergis U, Beitinjaneh A, Askar M, Pu JJ, Lehmann LE, Rangarajan HG, Wood WA, Hashmi S, Yano S, Kako S, Ozawa Y, Doki N, Kanda Y, Fukuda T, Katayama Y, Ichinohe T, Tanaka J, Teshima T, Okamoto S, Atsuta Y, Saber W

2025 | Transplantation and Cellular Therapy

Choosing between HLA-mismatched unrelated and haploidentical donors: Donor age considerations.

Authors:

Mehta RS, Schmidt G, Williams K, Patel SA, Schetelig J, Savani B, Askar M, Petersdorf E, Ringden O, Kanakry CG, Kanakry JA, Stefanski H, Arrieta-Bolaños E, Betts B, Benjamin C, Gadalla S, Wang T, Saultz J, Spellman S, Jurdi NE, Bolon YT, Lee SJ

2025 | Transplantation and Cellular Therapy

Current activity trends and outcomes in hematopoietic cell transplantation and cellular therapy – a report from the CIBMTR transplantation and cellular therapy.

Authors:

Spellman SR, Xu S, Oloyede T, Ahn KW, Akhtar OS, Bolon YT, Broglie LA, Bloomquist J, Bupp C, Chen M, Devine SM, El-Jurdi N, Hamadani M, Hengen M, Huppler AH, Jaglowski S, Kuxhausen M, Lee SJ, Moskop A, Page KM, Pasquini MC, Pérez WS, Phelan R, Rizzo JD, Saber W, Stefanski HE, Steinert P, Tuschl E, Visotcky A, Vogel R, Auletta JJ, Shaw BE, Allbee-Johnson M

2025 | Journal for Immunotherapy of Cancer (JI...

Regional distribution of HLA frequencies in the USA: implications for TCR-based therapies.

Authors:

Roy C, Sewastianik T, Saenz I, Opiteck GJ, Stagg S, Maiers M, Nagorsen D

2025 | Human Immunology

Profiling the genetic diversity of the HLA system in Mexico using 9-locus allele and haplotype frequencies from donors in the NMDP Mexico donor center.

Authors:

Madbouly A, Bashyal P, Baños A, Ramirez J, Whitaker C, Fernandez-Viña M, Springer B, Ybarra Y, Maiers M, Bolon YT

2025 | Transplantation and Cellular Therapy

Allele and haplotype frequencies in high-resolution typing of human leukocyte antigen -A, -B, -C, -DRB1, -DQB1 and -DPB1 in Thai voluntary stem cell donors.

Authors:

Khanuntong S, Tupmongkol T, Phiancharoen S, Tiyapan A, Kupatawintu P, Chaiwanichsiri D, Maiers M, Chiewsilp P

2025 | Cytotherapy

Immune monitoring after cell therapy and hematopoietic cell transplantation: Guidelines by the ISCT stem cell engineering committee.

Authors:

Oppizzi L, Hosszu K, Prockop S, Bidgoli A, Bonfim C, Ciccocioppo R, Ruggeri A, Maiers M, Bertaina A, Boelens JJ

2025 | Transplantation and Cellular Therapy

Out-of-pocket expenditures and financial hardship among patients with myelodysplastic syndrome undergoing allogeneic transplant or hypomethylating agent / supportive care (BMT CTN 1102).

Authors:

Su CT, Saber W, Bansal A, Li L, Nakamura R, Cutler C, Wright W, Steuten L, Roth JA, Ramsey SD

2025 | HLA

The registry of unmet need: A World Marrow Donor Association analysis of patients without an HLA match.

Authors:

Maiers M, Greco-Stewart V, Madbouly A, Robinson J, Eberhard HP, Sauter J, Louzoun Y, Israeli S, Bolon YT, Pingel J, Schmidt AH, Spierings E, Leonhard-Melief C, Foeken L, Schuit M, Venter A, Marsh SGE

2025 | Blood Advances

Impact of post-transplant cyclophosphamide-based GVHD prophylaxis in patients 70 years and older: An update from BMT CTN 1703.

Authors:

Abedin SM, Martens MJ, Bolanos-Meade J, Al Malki MM, Lian Q, Runaas L, Elmariah H, Gooptu M, Larkin KT, Shaffer BC, Loren AW, Solh MM, Alousi AM, Jamy O, Perales MA, Rezvani AR, Bhatt AS, El Jurdi N, Yao JM, Applegate K, Kean LS, Efebera YA, Reshef R, Clark WB, Leifer E, Saber W, Horowitz MM, Jones RJ, Holtan SG, Hamadani M

2025 | Frontiers in Immunology

Long donor leukocyte telomeres raise risk of severe COVID-19 in recipients of allogeneic hematopoietic cell transplant.

Authors:

Mendez KJW, Lai TP, Spellman SR, Verhulst S, Anderson J, Saber W, Gadalla SM, Aviv A

2025 | Cell Reports Methods

Accurate prediction of absolute prokaryotic abundance from DNA concentration.

Authors:

Wirbel J, Andermann TM, Brooks EF, Evans L, Groth A, Dvorak M, Chakraborty, Palushaj Bianca, Reynolds GZM, Porter IE, Al Malki MM, Rezvani AR, Gooptu M, Elmariah H, Runaas L, Fei T, Martens MJ, Bolanos-Meade J, Hamadani M, Holtan S, Jenq R, Peled JU, Horowitz MM, Poston KL, Saber W, Kean LS, Perales MA, Bhatt AS

2025 | Transplantation and Cellular Therapy

Cytokine release syndrome and neurotoxicity following CD19 CAR-T in B-cell lymphoma.

Authors:

Shouval R, Strouse C, Kim S, Oloyede T, Ahmed S, Awan FT, Luan D, Bachanova V, Badar T, Bar M, Barba P, Beintinjaneh A, Cashen A, Dholaria B, Elsawy M, Ganguly S, Geethakumari PR, Greenbaum U, Hashmi H, Hill LC, Jain MD, Jain T, Kebriaei P, Kittai AS, Locke FL, Lulla PD, Mead E, McGuirk J, Mussetti A, Nishihori T, Olson AL, Pennisi M, Perales MA, Riedell PA, Saber W, Mirza AS, Magalhaes-Silverman M, Shpall EJ, Sorror M, Wudhikarn K, Turtle CJ, Moskop A, Pasquini MC

2025 | Genes and Immunity

Association between HLA genetics and SARS-CoV-2 infection in a large real-world cohort.

Authors:

Letovsky SI, Cao X, Hollenbach JA, Mack SJ, Maiers M

2025 | Blood Advances

Delayed T cell recovery after hematopoietic cell transplantation is associated with decreased overall survival in adults.

Authors:

Perales MA, Riches M, He N, Martens MJ, Chemaly RF, Dandoy CE, Hill JA, Díaz MA, Hashmi S, Prockop S, Lazarus HM, Beitinjaneh AM, Hildebrandt GC, Auletta JJ, Szabolcs P